📰 Total Identity News
Page 2 - Total Identity News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Total Identity. Real-time updates on events, politics, business and more.
August 3, 2023
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research report report published on Sunday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer lowered Conformis from an outperform rating to a market perform rating in a report on Tuesday, May 9th. Read Our Latest […]
July 5, 2023
Conformis, Inc. (NASDAQ:CFMS – Free Report) was the recipient of a large growth in short interest in June. As of June 15th, there was short interest totalling 347,500 shares, a growth of 30.5% from the May 31st total of 266,300 shares. Currently, 4.9% of the shares of the stock are sold short. Based on an […]
July 4, 2023
Conformis, Inc. (NASDAQ:CFMS – Free Report) was the recipient of a large increase in short interest in the month of June. As of June 15th, there was short interest totalling 347,500 shares, an increase of 30.5% from the May 31st total of 266,300 shares. Approximately 4.9% of the company’s shares are sold short. Based on […]
July 2, 2023
StockNews.com initiated coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a report released on Wednesday morning. The firm issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer lowered shares of Conformis from an outperform rating to a market perform rating in a research note on Tuesday, May 9th. Conformis Trading […]
June 30, 2023
Equities research analysts at StockNews.com began coverage on shares of Conformis (NASDAQ:CFMS – Free Report) in a research report issued on Wednesday. The firm set a “hold” rating on the medical instruments supplier’s stock. Separately, Oppenheimer downgraded Conformis from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 9th. […]
June 24, 2023
StockNews.com began coverage on shares of Conformis (NASDAQ:CFMS – Get Rating) in a report published on Tuesday morning. The firm issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer cut Conformis from an outperform rating to a market perform rating in a research note on Tuesday, May 9th. Conformis Trading Up 87.1 […]
June 23, 2023
StockNews.com started coverage on shares of Conformis (NASDAQ:CFMS – Get Rating) in a report issued on Tuesday morning. The firm issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer lowered shares of Conformis from an outperform rating to a market perform rating in a research report on Tuesday, May 9th. Conformis Stock […]
June 21, 2023
StockNews.com assumed coverage on shares of Conformis (NASDAQ:CFMS – Get Rating) in a research report sent to investors on Tuesday morning. The firm issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer cut shares of Conformis from an outperform rating to a market perform rating in a report on Tuesday, May 9th. […]
June 16, 2023
StockNews.com started coverage on shares of Conformis (NASDAQ:CFMS – Get Rating) in a research report released on Monday. The brokerage issued a hold rating on the medical instruments supplier’s stock. Separately, Oppenheimer lowered shares of Conformis from an outperform rating to a market perform rating in a research note on Tuesday, May 9th. Conformis Stock […]
June 14, 2023
Research analysts at StockNews.com started coverage on shares of Conformis (NASDAQ:CFMS – Get Rating) in a report issued on Monday. The brokerage set a “hold” rating on the medical instruments supplier’s stock. Separately, Oppenheimer cut shares of Conformis from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 9th. […]